Insider · CIK 0001585699

Mates Sharon

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001585699

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-30	SPTXSeaport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+49K sh	—	—	49,033
2026-01-22	BNTCBenitec Biopharma Inc. · Options (right to buy)A Award	Director	AAward	+31.5K sh	—	—	31,500
2025-12-01	BNTCBenitec Biopharma Inc. · Options (right to buy)A Award	Director	AAward	+3,500 sh	—	—	3,500
2025-11-05	BNTCBenitec Biopharma Inc. · Options (right to buy)A Award	Director	AAward	+28.5K sh	—	—	28,517
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−66.9K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Performance Stock UnitsD Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−40.7K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−53.5K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Performance Stock UnitsD Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−35K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−190K sh	$132.00	−$25.1M	0
2025-04-02	Intra-Cellular Therapies, Inc.Restricted Stock UnitsD Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−69.9K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Performance Stock UnitsA Award	Director, Chairman and CEO	AAward	+40.7K sh	—	—	40,712
2025-04-02	Intra-Cellular Therapies, Inc.Restricted Stock UnitsD Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−40.7K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Restricted Stock UnitsD Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−121K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−50.2K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−135K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−945K sh	$132.00	−$125M	0
2025-04-02	Intra-Cellular Therapies, Inc.Performance Stock UnitsA Award	Director, Chairman and CEO	AAward	+35K sh	—	—	34,970
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−86K sh	—	—	0
2025-04-02	Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−138K sh	—	—	0
2025-03-26	Intra-Cellular Therapies, Inc.G Gift	Director, Chairman and CEO	GGift	−190K sh	—	—	945,235
2025-03-26	Intra-Cellular Therapies, Inc.G Gift	Director, Chairman and CEO	GGift	+190K sh	—	—	190,000
2025-03-10	Intra-Cellular Therapies, Inc.M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+20.6K sh	—	—	1,145,364
2025-03-10	Intra-Cellular Therapies, Inc.F Tax Payment	Director, Chairman and CEO	FTax Payment	−10.1K sh	$131.24	−$1.33M	1,135,235
2025-03-10	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−20.6K sh	—	—	0
2025-03-06	Intra-Cellular Therapies, Inc.F Tax Payment	Director, Chairman and CEO	FTax Payment	−19.8K sh	$131.19	−$2.6M	1,124,798
2025-03-06	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−40.7K sh	—	—	40,713
2025-03-06	Intra-Cellular Therapies, Inc.M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+40.7K sh	—	—	1,144,646
2025-03-01	Intra-Cellular Therapies, Inc.M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+35K sh	—	—	1,120,912
2025-03-01	Intra-Cellular Therapies, Inc.F Tax Payment	Director, Chairman and CEO	FTax Payment	−17K sh	$128.20	−$2.18M	1,103,934
2025-03-01	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−35K sh	—	—	69,940
2025-02-03	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	Director, Chairman and CEO	AAward	+121K sh	—	—	121,212
2025-01-31	Intra-Cellular Therapies, Inc.A Award	Director, Chairman and CEO	AAward	+30.8K sh	—	—	1,101,176
2025-01-31	Intra-Cellular Therapies, Inc.F Tax Payment	Director, Chairman and CEO	FTax Payment	−15.2K sh	$127.00	−$1.93M	1,085,943
2024-12-05	Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−51.7K sh	—	—	0
2024-12-05	Intra-Cellular Therapies, Inc.S Sale	Director, Chairman and CEO	SSale	−1,534 sh	$84.69	−$130K	1,070,329
2024-12-05	Intra-Cellular Therapies, Inc.S Sale	Director, Chairman and CEO	SSale	−50.2K sh	$84.06	−$4.22M	1,071,863
2024-12-05	Intra-Cellular Therapies, Inc.M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+51.7K sh	$12.73	+$658K	1,122,026
2024-12-04	Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−51K sh	—	—	51,697
2024-12-04	Intra-Cellular Therapies, Inc.S Sale	Director, Chairman and CEO	SSale	−23.3K sh	$86.00	−$2.01M	1,070,329
2024-12-04	Intra-Cellular Therapies, Inc.S Sale	Director, Chairman and CEO	SSale	−27.7K sh	$85.62	−$2.37M	1,093,662
2024-12-04	Intra-Cellular Therapies, Inc.M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+51K sh	$12.73	+$649K	1,121,329
2024-08-30	Intra-Cellular Therapies, Inc.S Sale	Director, Chairman and CEO	SSale	−6,193 sh	$73.32	−$454K	1,070,329
2024-08-30	Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−34.4K sh	—	—	102,697
2024-08-30	Intra-Cellular Therapies, Inc.S Sale	Director, Chairman and CEO	SSale	−28.2K sh	$72.73	−$2.05M	1,076,522
2024-08-30	Intra-Cellular Therapies, Inc.M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+34.4K sh	$12.73	+$438K	1,104,725
2024-08-29	Intra-Cellular Therapies, Inc.S Sale	Director, Chairman and CEO	SSale	−5,772 sh	$73.25	−$423K	1,070,329
2024-08-29	Intra-Cellular Therapies, Inc.S Sale	Director, Chairman and CEO	SSale	−29.8K sh	$72.44	−$2.16M	1,076,101
2024-08-29	Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−35.6K sh	—	—	137,093
2024-08-29	Intra-Cellular Therapies, Inc.M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+35.6K sh	$12.73	+$453K	1,105,933
2024-08-28	Intra-Cellular Therapies, Inc.M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+32.7K sh	$17.57	+$575K	1,103,028

Recent filings

Accepted (ET)
May 44
Mates Sharon0001193125-26-204449
SEC(opens sec.gov)
Jan 264
Mates Sharon0001012975-26-000082
SEC(opens sec.gov)
Dec 34
Mates Sharon0001012975-25-000851
SEC(opens sec.gov)
Nov 74
Mates Sharon0001012975-25-000718
SEC(opens sec.gov)
Apr 24
Mates Sharon0000950170-25-049595
SEC(opens sec.gov)
Mar 314
Mates Sharon0000950170-25-047937
SEC(opens sec.gov)

Companies

Address

SEAPORT THERAPEUTICS, INC. 101 SEAPORT BLVD., FLOOR 12

BOSTON, MA, 02210